With the approval of the first ‘digital medicine’ last year, a new digital wave is hitting pharma. What does it look like and how transformative is its potential?
With its strong heritage in collaboration and cutting-edge science, pharma is perfectly placed to embrace technology and deliver a new generation of interventions, says Bayer Chief Marketing Officer, Sebastian Guth.